Cargando…
Effectiveness and persistence of golimumab as a second biological drug in patients with spondyloarthritis: A retrospective study
This observational, longitudinal retrospective, noncomparative study was designed to assess the persistence and effectiveness of golimumab as a second anti-tumor necrosis factor (TNF) drug in patients with spondyloarthritis requiring discontinuation from a first anti-TNF drug. Data were collected re...
Autores principales: | Alegre-Sancho, Juan J., Juanola, Xavier, Rodríguez-Heredia, José M., Manero, Javier, Villa-Blanco, Ignacio, Laiz, Ana, Arteaga, María J., Cea-Calvo, Luis, González, Carlos M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021319/ https://www.ncbi.nlm.nih.gov/pubmed/33787605 http://dx.doi.org/10.1097/MD.0000000000025223 |
Ejemplares similares
-
Two years follow-up of golimumab treatment in refractory enteropathic spondyloarthritis patients with Crohn disease: A STROBE-compliant study
por: Conigliaro, Paola, et al.
Publicado: (2021) -
Opsonic and Antibody Responses to Pneumococcal Polysaccharide in Rheumatoid Arthritis Patients Receiving Golimumab Plus Methotrexate
por: Migita, Kiyoshi, et al.
Publicado: (2015) -
Immunohistological analysis of active sacroiliitis in patients with axial spondyloarthritis
por: Peng, Jianhua, et al.
Publicado: (2017) -
The value of repeat biopsy in lupus nephritis flares
por: Narváez, Javier, et al.
Publicado: (2017) -
Nonradiographic axial spondyloarthritis: expanding the spectrum of an old disease: A narrative review
por: Magrey, Marina, et al.
Publicado: (2022)